Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HIMS stock price vs NLY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NLY's multiple
Needs NLY P/E.
Implied fair value · at HIMS's multiple
Needs HIMS P/E.
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HIMS FY 2025 (ended Dec 31, 2025) · NLY FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 0% equity / 100% debt · EV / Revenue 0.47x · EV / EBITDA 7.55x
Capital structure 98% equity / 2% debt · EV / EBITDA 2.03x
NLY carries the larger enterprise value at $16.21B against $1.11B; NLY trades on the lower EV / EBITDA multiple (2.03x vs 7.55x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HIMS & HERS HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ANNALY CAPITAL MANAGEMENT INC · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.48x
0.03x
Net debt / EBITDA
Leverage against operating earnings
7.55x
-0.12x
Cash and equivalents
Liquid reserves on the balance sheet
$228.62M
$1.41B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Teladoc Health, Inc.
HIMS vs TDOC
GoodRx Holdings, Inc.
HIMS vs GDRX
CLOVER HEALTH INVESTMENTS, CORP. /DE
HIMS vs CLOV
Roivant Sciences Ltd.
HIMS vs ROIV
AGNC Investment Corp.
HIMS vs AGNC
TWO HARBORS INVESTMENT CORP.
HIMS vs TWO
Armour Residential REIT, Inc.
HIMS vs ARR
STARWOOD PROPERTY TRUST, INC.
HIMS vs STWD
DYNEX CAPITAL INC
HIMS vs DX
$1.34B
$429.65M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
